Overexpression of gastrin-releasing peptide (GRP) receptor (GRPR) in both androgen-
dependent (AD) and androgen-independent (AI) human neoplastic prostate tissues provides …

The gastrin-releasing peptide receptor (GRPR) is found to be overexpressed in a variety of
human tumors. The aim of this study was to develop 18F-labeled bombesin analogs for PET …

Gastrin-releasing peptide (GRP) receptors (GRPr) are frequently overexpressed in human
prostate cancer, and radiolabeled GRPr affinity ligands have shown promise for in vivo …

Bombesin is a peptide exhibiting high affinity for the gastrin-releasing peptide receptor
(GRPr), which is highly overexpressed on prostate cancer cells. In the present study, we …

Bombesin (BBN), an analog of human gastrin-releasing peptide (GRP), binds to the GRP
receptor (GRPR) with high affinity and specificity. Overexpression of GRPR has been …

Gastrin-releasing peptide receptor (GRPR) is overexpressed in human prostate cancer and
is being used as a target for molecular imaging. In this study, we report on the direct …

Human prostate cancers (PC) overexpress gastrin-releasing peptide (GRP) receptors. This
observation suggests that GRP receptors may be used as new visualization and treatment …

The gastrin-releasing peptide receptor (GRPR) is overexpressed in a variety of human
malignancies, including prostate cancer. Bombesin (BBN) is a 14 amino acids peptide that …

Gastrin-releasing peptide receptors (GRP-R) are upregulated in many cancers, including
prostate, breast, and lung. We describe a new radiolabeled bombesin (BBN) analog for …

Ex vivo studies have shown that the gastrin releasing peptide receptor (GRPr) is
overexpressed on almost all primary prostate cancers, making it a promising target for …